The European Union’s drug regulator will this week consider wider use of Novo Nordisk’s weight-loss drug Wegovy to include reducing the risk of strokes and heart attacks. Approval could help the Danish drugmaker better argue its case for making the drug available via public sector health systems in Europe. The possible new use of Wegovy, based on a drug trial …
Read More »EU watchdog to consider wider use of Wegovy weight-loss drug
January 24, 2024